Search Results - "Oba, K."
-
1
Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer
Published in British journal of surgery (01-09-2019)“…Background Accumulating evidence suggests that radiotherapy success has an immune‐associated component. The immunogenomic profiles associated with responses to…”
Get full text
Journal Article -
2
SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer
Published in European journal of cancer (1990) (01-09-2019)“…Fluorouracil (5-FU), leucovorin (LV) and oxaliplatin (FOLFOX) plus panitumumab therapy is a commonly used first-line chemotherapy for metastatic colorectal…”
Get full text
Journal Article -
3
Prognostic significance of epithelial–mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray
Published in British journal of cancer (23-09-2014)“…Background: Epithelial–mesenchymal transition (EMT) is characterised by the loss of cell-to-cell adhesion and gaining of mesenchymal phenotypes…”
Get full text
Journal Article -
4
Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer
Published in BJS open (01-12-2019)“…Background There is a lack of large studies focusing on the prognostic significance of lateral lymph node (LLN) metastasis following LLN dissection (LLND) in…”
Get full text
Journal Article -
5
FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study
Published in Annals of oncology (01-07-2015)“…A targeted agent combined with chemotherapy is the standard treatment in patients with metastatic colorectal cancer (mCRC). The present phase III study was…”
Get full text
Journal Article -
6
Relation of overall survival, progression free survival, post progression survival and response rate in four randomized Japanese phase III trials comparing various combinations of S-1 therapy for first-line treatment of advanced gastric cancer
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
7
-
8
-
9
A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy for colorectal cancer: The AIRS study
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
10
-
11
Long-term outcome in Japanese patients with lupus nephritis
Published in Lupus (01-10-2014)“…The objective of this study was to clarify the long-term outcome in patients with lupus nephritis (LN) according to the International Society of Nephrology and…”
Get full text
Journal Article -
12
-
13
-
14
-
15
-
16
Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)
Published in Bone marrow transplantation (Basingstoke) (01-11-2013)“…In this study, outcomes for 575 adult ALL patients aged ⩾45 years who underwent first allo-SCT in CR were analyzed according to the type of conditioning…”
Get full text
Journal Article -
17
Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7
Published in ESMO open (01-04-2021)“…Although the efficacy of trifluridine/tipiracil (FTD/TPI) plus bevacizumab (BEV) against metastatic colorectal cancer (mCRC) has been demonstrated, little is…”
Get full text
Journal Article -
18
Phase III trial of short-course radiotherapy followed by CAPOXIRI versus CAPOX in locally advanced rectal cancer: the ENSEMBLE trial
Published in ESMO Gastrointestinal Oncology (01-10-2023)“…The two key concerns in treating locally advanced rectal cancer (LARC) are as follows: (i) prolonging survival by reducing distant metastases and (ii)…”
Get full text
Journal Article -
19
Commissioning Test Results of Variable-Temperature Helium Refrigerator/Liquefier for NIFS Superconducting Magnet Test Facility
Published in IEEE transactions on applied superconductivity (01-04-2016)“…The superconducting magnet test facility in the National Institute for Fusion Science has been upgraded for excitation tests at a wide temperature range and a…”
Get full text
Journal Article -
20